Advertisement
Pharma/Biotech News
Subscribe to Pharma/Biotech News

The Lead

Game Changing Migraine Med to be Available November 2014

October 31, 2014 12:54 pm | News | Comments

Migranade Inc announced the new migraine medication will be available to the 36 million U.S. migraine sufferers November 2014. Read more...                    

Daiichi Sankyo's Heart Drug Gets FDA Recommendation

October 31, 2014 10:11 am | News | Comments

Daiichi Sankyo announced that the FDA...

Profectus BioSciences Gets $9.5M DoD Funding for Ebola/Marburg Vaccine

October 31, 2014 10:00 am | News | Comments

Profectus BioSciences Inc. announced that the DoD...

Specialized Therapeutics' Cancer Drug to be PBS Listed

October 31, 2014 9:33 am | News | Comments

Australian biopharmaceutical company Specialized...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

TNIB to Start 90-Day HIV/AIDS Trial in Nigeria

October 30, 2014 1:16 pm | News | Comments

TNI BioTech Inc., a specialty pharmaceutical company involved in the manufacture, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, through its wholly owned subsidiary TNI BioTech International Ltd., announces the initiation of a 90-day bridging trial in Nigeria of Lodonal in patients with HIV/AIDS. Read more...

FDA Approves Generic Alzheimer's Drug

October 30, 2014 12:52 pm | News | Comments

TWi Pharmaceuticals Inc. announced that it has received final approval from the FDA on its Abbreviated New Drug Application (ANDA) for Donepezil Hydrochloride Tablets USP, 23 mg, the generic equivalent to Eisai Inc.'s Aricept 23mg. Read more...     

AstraZeneca's Diabetes Treatment Gets FDA Approval

October 30, 2014 12:00 pm | News | Comments

AstraZeneca announced that the FDA has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes. Read more...                 

Advertisement

NeuroDerm Announces Positive Phase 2 Results of Parkinsons Vaccine

October 30, 2014 9:49 am | News | Comments

NeuroDerm announced positive phase 2 results for a new Parkinsons vaccine. Read more...                             

Pfizer Gains FDA Approval for Meningococcal B Vaccine

October 30, 2014 9:14 am | News | Comments

Pfizer announced that the FDA has granted accelerated approval of a new meningococcal vaccine. Read more...                          

Sanofi Ousts CEO Over Management Style, Sales Drop

October 29, 2014 11:55 am | by Greg Keller - Associated Press | News | Comments

French drugmaker Sanofi sacked its CEO following a board room rift over his way of handling one of France's largest publicly traded companies. Read more...                  

Pfizer's Antidepressant May Not Affect Sexual Function

October 29, 2014 10:19 am | News | Comments

Pfizer Inc. announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder (MDD) treated daily with Pristiq Extended Release Tablets 50mg and 100mg doses versus placebo. Read more...

Boehringer Ingelheim, Lilly Restructure Diabetes Alliance

October 29, 2014 10:01 am | News | Comments

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain countries. Read more...

Advertisement

J&J Launches Asia Pacific Innovation Center

October 28, 2014 5:33 pm | News | Comments

Johnson & Johnson Innovation announced the opening of the Asia Pacific Innovation Center, located in Shanghai with satellites in Singapore, Australia and Japan. Read more...                                   

Boehringer Ingelheim Present Data on COPD Drug

October 28, 2014 1:22 pm | News | Comments

Boehringer Ingelheim presented data from the ANHELTO 1&2 studies that evaluated the co-administration of Spiriva HandiHaler plus Striverdi Respimat Inhalation Spray inhaler in patients with COPD. Read more...

BDSI Developing Long-Acting Vaccine for Pain Treatment

October 28, 2014 1:21 pm | News | Comments

BioDelivery Sciences International is developing a long-acting injectable for use in pain treatments. Read more...                        

Amgen Plans More Job Cuts

October 28, 2014 12:50 pm | News | Comments

The world's biggest biotech drugmaker said that it plans to eliminate an additional 600 to 1,100 positions in 2015. Read more....                    

New Trial Will Explore Heart Disease Prevention in People with HIV

October 28, 2014 9:44 am | News | Comments

The National Institutes of Health and The National Heart, Lung and Blood Institute are initiating a landmark multimillion dollar outcomes trial utilizing pitavastatin for the primary prevention of cardiovascular disease in persons infected with HIV. Read more... 

Advertisement

BMS Acquires Worldwide Rights For New Breast Cancer Therapy

October 28, 2014 8:57 am | News | Comments

Bristol-Myers Squibb Company entered into an agreement F-star Alpha to acquire the company and gain worldwide rights to a targeted therapy that can treat breast and gastric cancer. Read more...           

Merck Announces New Breakthrough Therapy Designation for Lung Cancer

October 27, 2014 1:37 pm | News | Comments

Merck announced that the FDA granted Breakthrough Therapy Designation for the treatment of lung cancer. Read more...                        

Valeant: We'll Bump Allergan Offer to $200 a Share

October 27, 2014 11:03 am | News | Comments

The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12%, which would mean $200 or more per share for the maker of Botox. Read more...

CSL to Acquire Novartis Influenza Vaccine Business

October 27, 2014 10:51 am | News | Comments

CSL Limited announced that it has agreed to acquire Novartis’ global influenza vaccine business for $275 million. The business will be combined with CSL’s subsidiary, bioCSL. Read more...

Drugmakers Bet on Ebola Vaccines, Treatments

October 27, 2014 10:46 am | by Matthew Perrone and Danica Kirka - Associated Press | News | Comments

Drugmakers are racing to develop vaccines and drugs to address the worst outbreak of Ebola in history. Read more...                        

Arbor Pharmaceuticals Announces FDA New Drug Approval

October 24, 2014 12:40 pm | News | Comments

Arbor Pharmaceuticals announced that the FDA) has approved its New Drug Application (NDA) for Sotylize (sotalol hydrochloride) oral solution. Read more...                                      

Baxter Announces FDA Approval For New Hemophilia Drug

October 24, 2014 12:27 pm | News | Comments

Baxter International Inc. announced that the FDA has approved Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. Read more...                           

Myriad Establishes New Tumor Research Lab in Europe

October 24, 2014 10:18 am | News | Comments

Myriad Genetics Inc. announced it has established a Tumor BRACAnalysis CDx laboratory in Europe. Read more...                                                        

Pfizer Wins Patent Case in Delaware District Court

October 23, 2014 12:42 pm | News | Comments

Pfizer Inc. announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules. Read more...           

Eli Lilly Adds $375M to Zymeworks Partnership

October 23, 2014 9:52 am | News | Comments

Eli Lilly and Zymeworks said they are expanding a cancer drug development partnership. Read more...                                                   

Sutro BioPharma and Celgene Announce New Collaboration Plan

October 23, 2014 9:41 am | News | Comments

Sutro Biopharma announced it has entered into a strategic collaboration and option agreement with Celgene Corporation to discover and develop multispecific antibodies and antibody drug conjugates. Read more...                

PhosImmune, PureMHC Working Together on Cancer Immunotherapies

October 22, 2014 1:28 pm | News | Comments

PhosImmune Inc. and PureMHC LLC announced they have entered into a license and collaboration agreement to develop novel antibody-based immunotherapies designed to target cancers. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading